Created at	Source	Raw Value	Validated value
June 30, 2022, 4:30 p.m.	oms	Proportion of patients with clinical symptom requiring hospitalization; oxygen therapy; or experiencing mortality due to SARS-CoV-2 Infection (Part 1);Proportion of patients with negative conversion in nasopharyngeal swab specimen based on RT-qPCR at each visit (Part 1);Time to negative conversion in nasopharyngeal swab specimen (Part 1);Time to clinical recovery (Part 1);Proportion of patients with clinical symptom requiring hospitalization; oxygen therapy; or experiencing mortality due to SARS-CoV-2 Infection in high-risk patients (Part 2)	Proportion of patients with clinical symptom requiring hospitalization; oxygen therapy; or experiencing mortality due to SARS-CoV-2 Infection (Part 1);Proportion of patients with negative conversion in nasopharyngeal swab specimen based on RT-qPCR at each visit (Part 1);Time to negative conversion in nasopharyngeal swab specimen (Part 1);Time to clinical recovery (Part 1);Proportion of patients with clinical symptom requiring hospitalization; oxygen therapy; or experiencing mortality due to SARS-CoV-2 Infection in high-risk patients (Part 2)
Dec. 4, 2021, midnight	oms	To demonstrate the clinically meaningful therapeutic efficacy of CT-P59 as determined by proportion of patients with clinical symptom requiring hospitalization; oxygen therapy; or experiencing mortality due to SARS-CoV-2 infection in high-risk patients;Time to clinical recovery;Time to negative conversion in nasopharyngeal swab specimen based on RT-qPCR or cell culture	To demonstrate the clinically meaningful therapeutic efficacy of CT-P59 as determined by proportion of patients with clinical symptom requiring hospitalization; oxygen therapy; or experiencing mortality due to SARS-CoV-2 infection in high-risk patients;Time to clinical recovery;Time to negative conversion in nasopharyngeal swab specimen based on RT-qPCR or cell culture
July 30, 2021, 1:30 p.m.	oms	Time to negative conversion in nasopharyngeal swab specimen based on RT-qPCR or cell culture;Time to clinical recovery	Time to negative conversion in nasopharyngeal swab specimen based on RT-qPCR or cell culture;Time to clinical recovery